Skip to main content
Download PDF
  • Research article
  • Open access
  • Published:

Macrophage inhibits the osteogenesis of fibroblasts in ultrahigh molecular weight polyethylene (UHMWPE) wear particle-induced osteolysis

Journal of Orthopaedic Surgery and Research volume 14, Article number: 80 (2019) Cite this article

Abstract

Background

In the ultrahigh molecular weight polyethylene (UHMWPE) prosthetic environment, fibroblasts affected by wear particles have the capacity of osteogenesis to reduce osteolysis. We aimed to assess the effects of macrophages on the osteogenic capability of fibroblasts treated with UHMWPE wear particles.

Methods

The effect of different concentrations of UHMWPE (0, 0.01, 0.1, and 1 mg/ml, respectively) on macrophage proliferation were validated by MTT assay to determine the optimum one. The fibroblasts viability was further determined in the co-culture system of UHMWPE particles and macrophage supernatants. The experiment was designed as seven groups: (A) fibroblasts only; (B) fibroblasts + 1 mg/ml UHMWPE particles; and (C1–C5) fibroblasts + 1/16, 1/8, 1/4, 1/2, and 1/1 supernatants of macrophage cultures stimulated by 1 mg/ml UHMWPE particles vs. fibroblast complete media, respectively. Alizarin red staining was used to detect calcium accumulation. The expression levels of osteogenic proteins were detected by Western blot and ELISA, including alkaline phosphatase (ALP) and osteocalcin (OCN).

Results

The concentration of 0.1 mg/ml was considered as the optimum concentration for macrophage proliferation due to the survival rate and was highest among the four concentrations. Fibroblast viability was better in the group of fibroblasts + 1/16 ratio of macrophage supernatants stimulated by 1 mg/ml of UHMWPE particles than the other groups (1:8, 1:4, 1:2, 1:1). ALP and OCN expressions were significantly decreased in the group of fibroblasts + 1/4, 1/2, and 1/1 supernatants stimulated by 1 mg/ml of UHMWPE particles compared with other groups (1/8, 1/16) and the group of fibroblasts + 1 mg/ml UHMWPE (p < 0.5).

Conclusions

Macrophages are potentially involved in the periprosthetic osteolysis by reducing the osteogenic capability of fibroblasts treated with wear particles generated from UHMWPE materials in total hip arthroplasty.

Introduction

Periprosthetic osteolysis provoking aseptic loosening of the implant results in the failure of total hip arthroplasty (THA) and boosts a requirement of revision surgery [1]. Ultrahigh molecular weight polyethylene (UHMWPE) has been widely used as prosthesis materials for total joint replacements due to its excellent biocompatibility, low friction coefficient, and corrosion resistance properties [2]. Wear-generated particle debris promotes periprosthetic osteolysis, which is referred to as the progressive insidious bone resorption [3]. The prosthesis wear particles in the interfacial membrane (bone/prosthesis interface) stimulate various cell types in the periprosthetic area, such as macrophages and fibroblasts, leading to osteolysis [1]. Previous studies reported that interface membrane fibroblasts, affected by inflammatory cytokines, especially by wear particles, significantly contribute to osteoclast genesis and periprosthetic osteolysis [4, 5]. Many researchers have found that macrophages play a critical role in periprosthetic osteolysis by actively phagocytosing wear particles and produce inflammatory cytokines, leading to the imbalance of osteoclastic bone resorption and osteoblastic bone formation [6,7,8].

Macrophage is one of the major cell components in the prosthetic milieu and plays a critical role in the different foreign body responses. During the process of phagocytosis, macrophages released prostaglandins, cytokines, metalloproteinases, and lysosomal enzymes by wear particle stimulation which leads to activation of bone resorbing pathways [9, 10]. Macrophages were also reported to enhance osteogenesis of mouse clonal osteoblast-like cells (MC3T3) in vitro in the presence of calcium silicate cement via the bone morphogenetic protein-2 (BMP2) signaling pathway [11, 12]. So far, most studies focus on the effect of UHMWPE particles on macrophage secretions [13, 14]. The effects of macrophages on fibroblasts induced by UHMWPE particles remain unclear. As previously reported, the secretion of macrophages plays an important role in enhancing osteogenesis of fibroblasts [12]. Our previous results demonstrated that fibroblasts derived from the synovial membrane can be converted into osteoblasts by UHMWPE wear particles [15]. We proposed a hypothesis that macrophages participate in the periprosthetic osteolysis process by reducing the osteogenic capability of fibroblasts treated with UHMWPE wear particles. In the present study, we investigate the role of macrophage secretion on the in vitro biological activities of fibroblasts, especially the osteogenic capability, upon the stimulation by the UHMWPE wear particles.

Materials and methods

Fibroblasts and macrophage cultures

Fibroblasts were isolated from the hip synovial membrane of patients with femoral neck fracture during THA. Fibroblasts were cultured in Dulbecco’s modified Eagle’s medium (DMEM) containing 100 U/mL penicillin and 100 μg/mL streptomycin supplemented with 20% heat-inactivated fetal bovine serum (FBS) (Gibco, USA). Murine macrophage cell line Ana-1 (GNM2, Cell bank, China) were cultured in RPMI-1640 (Gibco, NY, Grand Island, USA) supplemented with 1.5 g/L NaHCO3, 2.5 g/L glucose, 0.11 g/L sodium pyruvate, and 10% FBS at 37 °C, 5% CO2.

Preparation of UHMWPE particles

UHMWPE particles with an average diameter of 6.54 μm ± 4.43 μm were prepared using a ball milling technique and imaged by scanning electron microscope (SEM, Quanta-200, FEI, Netherlands). UHMWPE wear particles in diameters of 53–75 μm were purchased from Sigma-Aldrich, USA. UHMWPE particles could mimic UHMWPE lining separated during the artificial hip revision procedures, which were analyzed and identified by using Raman spectrometer (HORIBA JobinYvon S.A.S, France). All the procedures were performed as previously reported [15]. Informed consent was obtained from all patients. The study was approved by the Ethics Committee of XiangYa Hospital, Central South University, China. The procedures were performed in accordance with the international ethics standards of human trials.

3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay

To determine the proliferation of macrophages in different concentrations of UHMWPE particles and to explore the optimum concentration, MTT assay was adopted to detect the cell viability [16]. Macrophages of logarithmic growth phase were seeded in a 96-well plate at a density of 1 × 104 cells/100 μl per well. Various concentrations of UHMWPE particles (0, 0.01, 0.1, and 1 mg/ml) were incubated with macrophages for 24 h at 37 °C in a humidified incubator at the atmosphere of 5% CO2. Macrophages without UHMWPE particles were treated as the negative control. Serum-free medium (100 μl) and 5 mg/ml MTT (20 μl, Sigma, USA) was further added into each well and subsequently incubated for 4 h. Following the removal of supernatant, the insoluble formazan crystals were dissolved in 150 μl dimethyl sulfoxide (DMSO), and absorbance at days 1, 3, 5, and 7 was measured by microplate reader (Bio-Rad, USA) at the 570-nm wavelength. Cell survival rate is (%) = [OD (particle-treated group)/OD (control)] × 100%.

To investigate the effect of macrophages treated by 1 mg/ml UHMWPE particles on the viability of fibroblasts, the supernatant was collected at 48 h. According to the different proportions of macrophage supernatants vs. fibroblast media, the co-culture system was divided into seven groups as follows: (A) fibroblasts only, (B) fibroblasts + 1 mg/ml UHMWPE particles, and (C1–C5) fibroblasts + 1/16, 1/8, 1/4, 1/2, and 1/1 of macrophage supernatants stimulated by 1 mg/ml of UHMWPE particles, respectively. The ratios of 1/16, 1/8, 1/4, 1/2, and 1/1 were defined as the proportion of macrophage supernatants vs. fibroblast complete media. MTT assays were performed as previously mentioned.

Alizarin red staining

To explore the effect of macrophage secretion on fibroblast osteogenic differentiation, alizarin red staining was used to detect the matrix mineralization, a process that occurs at the later stages of bone formation in all groups. In brief, cell specimens were washed with PBS and were fixed in 95% ethanol for 10 min. The sections were stained by alizarin red solution [17].

Western blot

Extracted protein was harvested at day 5 from the following co-culture systems: (A) fibroblasts only, (B) fibroblasts + 1 mg/ml UHMWPE particles, and (C1) fibroblasts + 1/16 macrophage supernatants stimulated by 1 mg/ml of UHMWPE particles. The protein was extracted with RIPA lysis buffer with phenylmethylsulfonyl fluoride (PMSF). The total protein was quantified by using a BCA Protein Assay kit (Thermo Scientific, USA) according to the manufacturer’s instructions [18]. Thereafter, 50 μg of extracted protein was boiled at 99 °C for 5 min in 1 × loading buffer and chilled down on ice. The electrophoresis was performed in 10% SDS-PAGE gels and then transferred onto polyvinylidene difluoride (PVDF) membranes. Non-specific binding was blocked by incubating with 5% fat-free milk in TBST buffer. After blocking the nonspecific sites with a blocking solution, the primary antibodies were incubated overnight at 4 °C, including anti-alkaline phosphatase (ALP) (1:10000, Abcam, ab133602, USA), anti-osteocalcin (OCN) (1:400; Santa Cruz, sc-74495, USA), and anti-GAPDH (1:800; Santa Cruz, sc-365062, USA). Subsequently, the membranes were washed with PBST followed by incubation with secondary goat anti-rabbit or goat anti-mouse horseradish peroxidase (HRP)-conjugated antibodies (Sigma, USA) for 1 h at room temperature. The blots were detected by an enhanced chemiluminescence (ECL) reagent (Pierce, USA). Bands were quantified by using the software of Gel-pro Analyzer 4.0.

Enzyme-linked immunosorbent assay (ELISA)

Serum-free DMEM was used for determining the OCN and ALP in the following co-culture systems: (A) fibroblasts only, (B) fibroblasts + 1 mg/ml UHMWPE particles, and (C1) fibroblasts + 1/16 supernatants stimulated by 1 mg/ml UHMWPE particles. OCN were assessed by enzyme-linked immunosorbent assay kit (SEA471Hu, Cloud-Clone Corp, USA). ALP activity was quantified by ELISA kit (SEB472Hu, Cloud-Clone Corp, USA) according to the instructions of the manufacturers. The optical densities (OD) were determined using a plate reader at 450 nm as previously reported [11, 19].

Statistical analysis

All quantitative data were expressed as the mean ± standard deviation (SD). Statistical analysis was performed with SPSS 17.0 software. Mean comparison was detected using one-way analysis of variance (ANOVA, n = 3), and p < 0.05 was considered statistically significant.

Results

A higher survival rate of macrophage at lower concentration of UHMWPE particles

Cell viability of macrophages was determined in the different concentrations of UHMWPE particles (Fig. 1). There was no statistical difference in the survival rate of macrophages between treated with 0.01 mg/ml UHMWPE particles and UHMWPE free controls at days 1, 3, 5, 7. However, there were significant differences in both macrophages + 0.1 mg/ml UHMWPE particles group and macrophages + 1 mg/ml UHMWPE particles group compared to macrophages only group (p < 0.01). In addition, the survival rate of macrophages was higher in macrophages + 0.1 mg/ml UHMWPE particles group than that in macrophages + 1 mg/ml UHMWPE particles group (p < 0.05). The results revealed that 0.1 mg/ml UHMWPE particles was the optimum concentration that stimulated for macrophage proliferation (Fig. 1).

Fig. 1
figure 1

Viability of macrophages treated with different concentrations of UHMWPE particles at days 1, 3, 5, and 7. One asterisk indicates p < 0.05, two asterisks indicate p < 0.01, and three asterisks indicate p < 0.001 between two groups

Full size image

Macrophage supernatant in the existence of UHMWPE particles reduced fibroblast survival rate

It is obvious that the survival rate of fibroblast was significantly higher in fibroblasts + 1 mg/ml UHMWPE particles group than that in fibroblasts with only control group (p < 0.001, group A vs. B). Cell viability of fibroblasts treated with 1 mg/ml UHMWPE particles was reduced as supernatants from macrophage cultures treated with 1 mg/ml of UHMWPE particles were added to the culture media (p < 0.01, Fig. 2a). Fibroblast survival rate was gradually decreased as the ratio of the macrophage supernatants increased. The results showed that proliferated or survived fibroblasts were better in the group of 1/16 macrophage supernatants from co-culture with 1 mg/ml of UHMWPE particles compared to other macrophage supernatant proportions accounting for fibroblasts’ complete media (p < 0.01, Fig. 2b).

Fig. 2
figure 2

Macrophage supernatants’ effect on the viability of fibroblasts treated with 1 mg/ml UHMWPE particles at day 5. Two asterisks indicate p < 0.01, three asterisks indicate p < 0.001 versus A (fibroblasts only); Two number signs indicate p < 0.01, three number signs indicate p < 0.001 versus B (fibroblasts + 1 mg/ml UHMWPE particles). a. fibroblasts only; b. fibroblasts + 1 mg/ml UHMWPE particles; C1-C5. fibroblasts + 1/16, 1/8, 1/4, 1/2, 1/1 of macrophage supernatants stimulated by 1mg/ml of UHMWPE particles, respectively

Full size image

Macrophage supernatant in the existence of UHMWPE wear particles reduced osteogenic capacity of fibroblasts

Calcium accumulation (red aggregate deposition) was more pronounced in the fibroblasts + 1 mg/ml UHMWPE particles group compared to fibroblasts with only control group. However, the staining intensity gradually decreased as the ratio of macrophage supernatants increased (Fig. 3).

Fig. 3
figure 3

Alizarin red staining of fibroblast treated with UHMWPE particles and added with macrophage supernatants (× 40)

Full size image

Macrophage supernatant upon the existence of UHMWPE wear particles reduced osteogenic protein secretion of fibroblasts

Protein expressions of the earlier osteogenic marker ALP and the late osteogenic markers OCN protein were obviously enhanced in fibroblasts + 1 mg/ml UHMWPE particles group compared to control group (fibroblasts only). However, the expression of the ALP and OCN protein gradually decreased as the ratio of macrophage supernatants vs. fibroblast completed media increased (Fig. 4a). ELISA results confirmed that the expressions of ALP and OCN were slightly reduced in fibroblasts + 1/16 and 1/8 macrophage supernatants group compared with fibroblasts + 1 mg/ml UHMWPE particles group (p > 0.05, Fig. 4b); however, a significant decrease was found while 1/4, 1/2, and 1/1 macrophage supernatants were added compared with fibroblasts + 1 mg/ml UHMWPE particles group (p < 0.05).

Fig. 4
figure 4

Osteogenic protein level of fibroblasts treated with UHMWPE particles and added with macrophage supernatants. a Western blot, b ELISA. One asterisk indicates p < 0.05, two asterisks indicate p < 0.01, three asterisks indicate p < 0.001 versus A (fibroblasts only); one number sign indicates p < 0.05, two number signs indicate p < 0.01, three number sign indicate p < 0.001 versus B (fibroblasts + 1 mg/ml UHMWPE particles). One plus sign indicates p < 0.05, two plus signs indicate p < 0.01, three plus signs indicate p < 0.001 versus C1 (fibroblasts + 1 mg/ml UHMWPE particles + 1/16 macrophage supernatants vs. fibroblast media)

Full size image

Discussion

Periprosthetic osteolysis, followed by implant loosening, is induced by UHMWPE wear particles and results in the failure of THA and the necessity of total joint revision procedures [20]. Related studies reported that approximately 10–50% of all revision THA can be attributed to periprosthetic osteolysis [21]. Wear debris, generated by articulating motion at the bearing surfaces, induces progressive osteolysis by increasing bone resorption and suppressing bone formation [22, 23]. Therefore, it is urgently essential to address the problem for the patients with end-stage osteoarthritis, avascular necrosis of the hip, or femoral neck fractures in THA [24]. The purpose of this study is to assess the effects of macrophages on the osteogenic capability of fibroblasts treated with UHMWPE wear particles. Our results confirmed that macrophages participate in the periprosthetic osteolysis process by reducing the osteogenic capability of fibroblasts treated with UHMWPE wear particles, and involved in the implant loosening. Currently, a variety of cells have been identified in the periprosthetic interfacial membrane (bone-implant interface), such as histiocytes, fibroblasts, endothelial cells, lymphocytes, osteoblasts, osteoclasts, and macrophages, while synovial-like membrane mainly consists of macrophages and fibroblasts [25, 26].

Our previous study demonstrated that fibroblasts stimulated by UHMWPE wear particles (1 mg/ml) have the capacity of forming osteoblast to reduce osteolysis [15]. It provided favorable evidence for clinical use of UHMWPE as prosthesis in THA as reported by other literature [27, 28]. It is well known that the macrophage response to UHMWPE wear debris plays a critical role in the long-term periprosthetic osteolysis [29]. Prosthetic particles, produced by wear at the articulating surface of prostheses are phagocytosed by macrophages [30]. This study was designed to investigate how macrophages participate in the processes of fibroblasts to osteoblast by stimulating UHMWPE wear particles.

Osteoblasts play a critical role in periprosthetic osteolysis, as normal bone metabolism commonly relies on the balance between bone formation and degradation, and either increased bone resorption or decreased bone formation can lead to the loss of bone stock [31]. Wear particles have been presented to exert a negative effect on osteoblasts during the process of osteolysis. In our work, fibroblasts were successfully separated from the hip synovial membrane during THA or revision procedures, and UHMWPE particles with desired sizes (average diameter 6.54 μm ± 4.43 μm) and various shapes were prepared through micro-grinding procedures. MTT results indicated that the survival rate of macrophages was significantly higher when it was treated with 0.1 mg/ml UHMWPE particles. Findings of the present study are consistent with Zaveri et al. [32] who reported that the optimum proliferation effect of fibroblasts for co-culture was stimulated by 0.1 mg/ml UHMWPE particles. A study by an American reported that the RAW264.7 cells with a density of 1 × 105/mL were most sensitive to the 0.1 mg/mL concentration of UHMWPE [33]. Macrophages are responsible for mediating foreign body immune reaction to wear particles from joint replacements [26]. Many studies reported that UHMWPE wear particles induced macrophage infiltration and inflammation leading to periprosthetic osteolysis through secreting inflammatory cytokines [29, 34]. According to the proportion of macrophage supernatants in fibroblast complete media, the co-culture system was divided into seven groups, besides the fibroblasts only group and fibroblasts + 1 mg/ml UHMWPE particles group. MTT results further indicated that fibroblasts treated with 1 mg/ml UHMWPE particles containing 1/16 of the corresponding macrophage supernatants had the highest cell viability among the macrophage supernatant treatment groups. We tried to mimic the effective joint space environment by culture of the fibroblasts with macrophage supernatants and UHMWPE wear particles. To date, methods for the treatment of wear debris-induced osteolysis have focused on the inhibition of inflammation and target osteoclasts [35]. ALP is a traditional marker of osteoblast differentiation and is related to the production of a mineralized osteoblast [36]. The Western blot and ELISA analysis were combined to explore the osteogenic ability of fibroblasts in the protein level, with mainly focusing on the ALP and OCN. Our results suggested that the osteogenic ability of fibroblasts treated with 1 mg/ml UHMWPE particles was reduced by adding macrophage supernatants to fibroblast complete media, just as the alizarin red staining showed. Wang et al. suggested that a lower expression of ALP and OCN in osteoprogenitor cells stimulated with Ti particles [37].

However, there are several limitations to our study. First is to mimic the effective joint space environment scenario. However, it has been demonstrated that these particles induced osteolysis around the prosthetic implant by mechanisms similar to polyethylene particles. An animal model study with continuous particle generation would provide a better conclusion in the future.

Conclusions

Thus, based on the data presented, we speculated that macrophages participate in the periprosthetic osteolysis process by reducing the osteogenic capability of fibroblasts treated with UHMWPE wear particles and involved in the implant loosening. This work strengthened our understanding about the complex bone-implant microenvironment in total hip arthroplasty.

Abbreviations

ALP:

Alkaline phosphatase

BMP 2:

Bone morphogenetic protein-2

DMSO:

Dimethyl sulfoxide

FBS:

Fetal bovine serum

HRP:

Horseradish peroxidase

MC3T3:

Mouse clonal osteoblast-like cells

OCN:

Osteocalcin

PMSF:

Phenylmethylsulphonyl fluoride

PVDF:

Polyvinylidene difluoride

THA:

Total hip arthroplasty

UHMWPE:

Ultrahigh molecular weight polyethylene

References

  1. Purdue PE, Koulouvaris P, Nestor BJ, Sculco TP. The central role of wear debris in periprosthetic osteolysis. HSS J. 2006;2(2):102–13.

    PubMed  PubMed Central  Google Scholar 

  2. Patel AK, Trivedi P, Balani K. Processing and mechanical characterization of compression-molded ultrahigh molecular weight polyethylene biocomposite reinforced with aluminum oxide. J NanoScience, NanoEngineering and Applications. 2014;4(3):1–11.

    Google Scholar 

  3. Gallo J, Goodman SB, Konttinen YT, Raska M. Particle disease: biologic mechanisms of periprosthetic osteolysis in total hip arthroplasty. Innate Immun. 2013;19(2):213–24.

    PubMed  Google Scholar 

  4. Koreny T, Tunyogi-Csapó M, Gál I, Vermes C, Jacobs JJ, Glant TT. The role of fibroblasts and fibroblast-derived factors in periprosthetic osteolysis. Arthritis Rheum. 2006;54(10):3221–32.

    CAS  PubMed  Google Scholar 

  5. Tunyogi-Csapo M, Koreny T, Vermes C, Galante JO, Jacobs JJ, Glant TT. Role of fibroblasts and fibroblast-derived growth factors in periprosthetic angiogenesis. J Orthop Res. 2007;25(10):1378–88.

    CAS  PubMed  Google Scholar 

  6. Rakshit DS, Ly K, Sengupta TK, Nestor BJ, Sculco TP, Ivashkiv LB, et al. Wear debris inhibition of anti-osteoclastogenic signaling by interleukin-6 and interferon-gamma. Mechanistic insights and implications for periprosthetic osteolysis. J Bone Joint Surg Am. 2006;88(4):788–99.

    PubMed  Google Scholar 

  7. Wright TM. CORR insights(®): periprosthetic UHMWPE wear debris induces inflammation, vascularization, and innervation after total disc replacement in the lumbar spine. Clin Orthop Relat Res. 2017;475(5):1369–81.

    Google Scholar 

  8. Jonitz-Heincke A, Lochner K, Schulze C, Pohle D, Pustlauk W, Hansmann D, et al. Contribution of human osteoblasts and macrophages to bone matrix degradation and proinflammatory cytokine release after exposure to abrasive endoprosthetic wear particles. Mol Med Rep. 2016;14(2):1491–500.

    CAS  PubMed  PubMed Central  Google Scholar 

  9. Bladen CL, Tzu-Yin L, Fisher J, Tipper JL. In vitro analysis of the cytotoxic and anti-inflammatory effects of antioxidant compounds used as additives in ultra high-molecular weight polyethylene in total joint replacement components. Journal of biomedical materials research Part B, Applied biomaterials. 2013;101(3):407–13.

  10. Lin T, Goodman SB. Suppression of NF-κB signaling mitigates polyethylene wear particle-induced inflammatory response. Inflamm Cell Signal. 2014;1(4):319–25.

    Google Scholar 

  11. Loi F, Córdova LA, Zhang R, Pajarinen J, Lin T-h, Goodman SB, et al. The effects of immunomodulation by macrophage subsets on osteogenesis in vitro. Stem Cell Res Ther. 2016;7(1):1–11.

    Google Scholar 

  12. Tu M-G, Chen Y-W, Shie M-Y. Macrophage-mediated osteogenesis activation in co-culture with osteoblast on calcium silicate cement. J Mater Sci Mater Med. 2015;26(12):1–10.

    CAS  Google Scholar 

  13. Neuerburg C, Loer T, Mittlmeier L, Polan C, Farkas Z, Holdt LM, et al. Impact of vitamin E-blended UHMWPE wear particles on the osseous microenvironment in polyethylene particle-induced osteolysis. International journal of molecular medicine. 2016;38(6):1652–60.

  14. Alias E, Dharmapatni A, Holding A, Atkins G, Findlay D, Howie D, et al. Polyethylene particles stimulate expression of ITAM-related molecules in peri-implant tissues and when stimulating osteoclastogenesis in vitro. Acta Biomater. 2012;8(8):3104–12.

    CAS  PubMed  Google Scholar 

  15. Dai Z, Lei P, Zhang YS, Liu H, Niu W, Li K, et al. Effect of stimulation by ultrahigh molecular weight polyethylene wear particles on the osteogenesis capability of fibroblasts. J Biomater Tissue Eng. 2018;8(5):723–30.

    Google Scholar 

  16. Zhang Y, Böse T, Unger RE, Jansen JA, Kirkpatrick CJ, van den Beucken JJJP. Macrophage type modulates osteogenic differentiation of adipose tissue MSCs. Cell and tissue research. 2017;369(2):273–86.

  17. Li T, Li H, Wang Y, Li T, Fan J, Xiao K, et al. microRNA-23a inhibits osteogenic differentiation of human bone marrow-derived mesenchymal stem cells by targeting LRP5. Int J Biochem Cell Biol. 2016;72:55–62.

    CAS  PubMed  Google Scholar 

  18. Wang H, He X-Q, Jin T, Li Y, Fan X-Y, Wang Y, et al. Wnt11 plays an important role in the osteogenesis of human mesenchymal stem cells in a PHA/FN/ALG composite scaffold: possible treatment for infected bone defect. Stem Cell Res Ther. 2016;7(1):1.

    Google Scholar 

  19. Hwang NS, Varghese S, Lee HJ, Zhang Z, Elisseeff J. Biomaterials directed in vivo osteogenic differentiation of mesenchymal cells derived from human embryonic stem cells. Tissue Eng A. 2013;19(15–16):1723–32.

    CAS  Google Scholar 

  20. Wang C-T, Lin Y-T, Chiang B-L, Lee S-S, Hou S-M. Over-expression of receptor activator of nuclear factor-κB ligand (RANKL), inflammatory cytokines, and chemokines in periprosthetic osteolysis of loosened total hip arthroplasty. Biomaterials. 2010;31(1):77–82.

    PubMed  Google Scholar 

  21. Beck RT, Illingworth KD, Saleh KJ. Review of periprosthetic osteolysis in total joint arthroplasty: an emphasis on host factors and future directions. J Orthop Res. 2012;30(4):541–6.

    PubMed  Google Scholar 

  22. Chiu R, Ma T, Smith RL, Goodman SB. Ultrahigh molecular weight polyethylene wear debris inhibits osteoprogenitor proliferation and differentiation in vitro. J Biomed Mater Res A. 2009;89(1):242–7.

    PubMed  Google Scholar 

  23. Jiang Y, Jia T, Wooley PH, Yang S-Y. Current research in the pathogenesis of aseptic implant loosening associated with particulate wear debris. Acta Orthop Belg. 2013;79(1):1–9.

    PubMed  Google Scholar 

  24. Green JM, Hallab NJ, Liao Y-S, Narayan V, Schwarz EM, Xie C. Anti-oxidation treatment of ultra high molecular weight polyethylene components to decrease periprosthetic osteolysis: evaluation of osteolytic and osteogenic properties of wear debris particles in a murine calvaria model. Curr Rheumatol Rep. 2013;15(5):1–5.

    CAS  Google Scholar 

  25. Agarwal S. Osteolysis—basic science, incidence and diagnosis. Curr Orthop. 2004;18(3):220–31.

    Google Scholar 

  26. Goodman SB. Wear particles, periprosthetic osteolysis and the immune system. Biomaterials. 2007;28(34):5044–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  27. Laurent MP, Johnson TS, Crowninshield RD, Blanchard CR, Bhambri SK, Yao JQ. Characterization of a highly cross-linked ultrahigh molecular-weight polyethylene in clinical use in total hip arthroplasty. J Arthroplast. 2008;23(5):751–61.

    Google Scholar 

  28. Oral E, Malhi AS, Wannomae KK, Muratoglu OK. Highly cross-linked ultrahigh molecular weight polyethylene with improved fatigue resistance for total joint arthroplasty: recipient of the 2006 Hap Paul Award. J Arthroplast. 2008;23(7):1037–44.

    Google Scholar 

  29. Matthews J, Mitchell W, Stone M, Fisher J, Ingham E. A novel three-dimensional tissue equivalent model to study the combined effects of cyclic mechanical strain and wear particles on the osteolytic potential of primary human macrophages in vitro. Proc Inst Mech Eng H J Eng Med. 2001;215(5):479–86.

    CAS  Google Scholar 

  30. Haynes D, Crotti T, Potter A, Loric M, Atkins G, Howie D, et al. The osteoclastogenic molecules RANKL and RANK are associated with periprosthetic osteolysis. J Bone Joint Surg, Br. 2001;83(6):902–11.

    CAS  Google Scholar 

  31. Alley C, Haggard W, Smith R. Effect of UHMWPE particle size, dose, and endotoxin on in vitro macrophage response. J Long-Term Eff Med Implants. 2014;24(1):45–56.

    CAS  PubMed  Google Scholar 

  32. Zaveri TD, Dolgova NV, Lewis JS, Hamaker K, Claresalzler MJ, Keselowsky BG. Macrophage integrins modulate response to ultra-high molecular weight polyethylene particles and direct particle-induced osteolysis. Biomaterials. 2017;115:128–40.

    CAS  PubMed  Google Scholar 

  33. Ren PG, Irani A, Huang Z, Ma T, Biswal S, Goodman SB. Continuous infusion of UHMWPE particles induces increased bone macrophages and osteolysis. Clin Orthop Relat Res®. 2011;469(1):113–22.

    Google Scholar 

  34. Lin T-h, Yao Z, Sato T, Keeney M, Li C, Pajarinen J, et al. Suppression of wear-particle-induced pro-inflammatory cytokine and chemokine production in macrophages via NF-κB decoy oligodeoxynucleotide: a preliminary report. Acta Biomater. 2014;10(8):3747–55.

    CAS  PubMed  PubMed Central  Google Scholar 

  35. Goodman SB, Gibon E, Pajarinen J, Lin TH, Keeney M, Ren PG, et al. Novel biological strategies for treatment of wear particle-induced periprosthetic osteolysis of orthopaedic implants for joint replacement. J R Soc Interface. 2014;11(93):20130962.

    CAS  PubMed  PubMed Central  Google Scholar 

  36. Zhang X, Zhang Y, Zhang X, Wang Y, Wang J, Lu M, et al. Mechanical properties and cytocompatibility of carbon fibre reinforced nano-hydroxyapatite/polyamide66 ternary biocomposite. J Mech Behav Biomed Mater. 2015;42(42C):267–73.

    PubMed  Google Scholar 

  37. Wang J, Tao Y, Ping Z, Wen Z, Hu X, Wang Y, et al. Icariin attenuates titanium-particle inhibition of bone formation by activating the Wnt/β-catenin signaling pathway in vivo and in vitro. Sci Rep. 2016;6:23827.

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

This research was performed mainly at the XiangYa Hospital, Central South University, China.

Funding

This study was supported by the Natural Science Foundation of Hunan Province, China (Grant No. 2018JJ3844), the Scientific Research Project of Health and Family Planning Commission of Hunan Province, China (Grant No. B2019188), the Youth Science Foundation of Xiangya Hospital Central South University (Grant No. 2017Q07), the Postdoctoral Research Program of Xiangya Hospital Central South University (Grant No. 223551),the Natural Science Foundation of Hunan Province, China (Grant No.12JJ2055); the China Scholarship Council (Grant No.201506370173); the National Natural Science Foundation of China (Grant No.31200739 and 31470948); and the Science and Technology Department Program of Zhejiang Province (Grant No. 2013C33156).

Availability of data and materials

All data generated or analyzed during this study are included in this article.

Author information

Authors and Affiliations

  1. Department of Orthopedics, Xiangya Hospital of Central South University, 87 Xiangya Road, Changsha, 410008, Hunan, People’s Republic of China

    Pengfei Lei, Kun Li, Long Wang, Yihe Hu & Jie Xie

  2. Department of Orthopedics, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine of Central South University, Changsha, 410008, Hunan, People’s Republic of China

    Zixun Dai

  3. Centre for Biomaterials Innovation, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Cambridge, MA, 02139, USA

    Yu Shrike Zhang

  4. Dr. Li Dak Sum & Yip Yio Chin Center for Stem Cell and Regenerative Medicine, School of Medicine, Zhejiang University, Hangzhou, 310058, People’s Republic of China

    Hua Liu

  5. Key Laboratory of Tissue Engineering and Regenerative Medicine of Zhejiang Province, Hangzhou, 310058, People’s Republic of China

    Hua Liu

  6. Harvard-MIT Division of Health Sciences and Technology, Tissue Engineering Lab, Cambridge, USA

    Hua Liu

  7. VA Boston Healthcare System, West Roxbury, MA, 02132, USA

    Wanting Niu

  8. Department of Orthopedics, Brigham and Women’s Hospital, Harvard Medical School, Cambridge, MA, 02139, USA

    Wanting Niu

Authors
  1. Pengfei Lei
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zixun Dai
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yu Shrike Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hua Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Wanting Niu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Kun Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Long Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Yihe Hu
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Jie Xie
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

PFL and ZXD conceived and coordinated the study; designed, performed, and analyzed the experiments; and wrote the paper. YSZ, HL, WTN, KL, and LW carried out the data collection and data analysis and revised the paper. YHH and JX designed the study and revised the manuscript. All authors reviewed the results and approved the final version of the manuscript.

Corresponding author

Correspondence to Jie Xie.

Ethics declarations

Ethics approval and consent to participate

The procedures were approved by the Ethics Committee of XiangYa Hospital, Central South University, China. The procedure was performed in accordance with the international ethics standards of human trials. Informed consent was obtained from all individual participants included in the study.

Consent for publication

All patients gave their written informed consent for the publication of their identifying photographs.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lei, P., Dai, Z., Zhang, Y.S. et al. Macrophage inhibits the osteogenesis of fibroblasts in ultrahigh molecular weight polyethylene (UHMWPE) wear particle-induced osteolysis. J Orthop Surg Res 14, 80 (2019). https://doi.org/10.1186/s13018-019-1119-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13018-019-1119-8

Keywords

Journal of Orthopaedic Surgery and Research

ISSN: 1749-799X